↓ Skip to main content

Therapeutic applications of mesenchymal stromal cells

Overview of attention for article published in Seminars in Cell & Developmental Biology, September 2007
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

patent
7 patents

Citations

dimensions_citation
207 Dimensions

Readers on

mendeley
147 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Therapeutic applications of mesenchymal stromal cells
Published in
Seminars in Cell & Developmental Biology, September 2007
DOI 10.1016/j.semcdb.2007.09.012
Pubmed ID
Authors

Gary Brooke, Matthew Cook, Chris Blair, Rachel Han, Celena Heazlewood, Ben Jones, Melinda Kambouris, Kate Kollar, Steven McTaggart, Rebecca Pelekanos, Alison Rice, Tony Rossetti, Kerry Atkinson

Abstract

Mesenchymal stromal cells (MSC) are multipotent cells that can be derived from many different organs and tissues. They have been demonstrated to play a role in tissue repair and regeneration in both preclinical and clinical studies. They also have remarkable immunosuppressive properties. We describe their application in settings that include the cardiovascular, central nervous, gastrointestinal, renal, orthopaedic and haematopoietic systems. Manufacturing of MSC for clinical trials is also discussed. Since tissue matching between MSC donor and recipient does not appear to be required, MSC may be the first cell type able to be used as an "off-the-shelf" therapeutic product.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 147 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
Netherlands 1 <1%
Sweden 1 <1%
Iran, Islamic Republic of 1 <1%
Canada 1 <1%
China 1 <1%
Poland 1 <1%
Unknown 139 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 29 20%
Student > Ph. D. Student 28 19%
Student > Master 25 17%
Student > Bachelor 17 12%
Other 7 5%
Other 21 14%
Unknown 20 14%
Readers by discipline Count As %
Agricultural and Biological Sciences 54 37%
Medicine and Dentistry 36 24%
Biochemistry, Genetics and Molecular Biology 13 9%
Neuroscience 2 1%
Materials Science 2 1%
Other 11 7%
Unknown 29 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 July 2020.
All research outputs
#3,798,287
of 25,373,627 outputs
Outputs from Seminars in Cell & Developmental Biology
#328
of 2,047 outputs
Outputs of similar age
#9,589
of 83,223 outputs
Outputs of similar age from Seminars in Cell & Developmental Biology
#2
of 17 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,047 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 83,223 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.